Name: Preimplantation Genetic Diagnosis Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: CD4323
Price: 4350 USD
Availability: InStock

Preimplantation Genetic Diagnosis Market Size Share Growth 2023-2030

Preimplantation Genetic Diagnosis Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Preimplantation Genetic Diagnosis Market&nbsp;is Segmented&nbsp;By Product Type (Reagents &amp; Consumables, Instruments, Software &amp; Services), By Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Comparative Genomic Hybridization (CGH), Other), By Application(Aneuploidy, Structural Chromosomal Abnormalities, Single Gene Disorders, X-linked Disorders, Gender Identification, Other)&nbsp;and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029.</h2>

<h2>&nbsp;</h2>

<blockquote>
The Preimplantation Genetic Diagnosis Market&nbsp;size&nbsp;is estimated to reach at a high <a href="https://www.datamintelligence.com/download-sample/preimplantation-genetic-diagnosis-market">CAGR</a> during the forecast period 2022-2029
</blockquote>

Preimplantation genetic testing is a technique used before pregnancy to detect genetic defects in embryos created through in vitro fertilization (IVF).

Preimplantation Genetic Diagnosis Market Scope:

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>
			High
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Product Type,&nbsp;By Technology, By Application,&nbsp;and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

<h3>Market Dynamics</h3>

Many factors are influencing the market growth of the preimplantation genetic diagnosis market. For instance, the advancement in diagnostic procedures in gene testing is expected to drive the market.

The advancement in the diagnostic procedures in gene testing is expected to drive the market in the forecast period

Many recent research developments in genomics have included the ongoing transition from traditional &lsquo;monogenic genetics to comprehensive testing of the human genome by integrating massively parallel sequencing approaches and advanced bioinformatics. Currently, it is possible to elucidate the entire human genome&#39;s single nucleotide variation (SNV), copy number variation (CNV), and structural variation (SV), i.e., beyond the original medical indication for which a patient (along with their family) were referred for genetic testing. These technological advances can be seen in expanded carrier screening (ECS), the elimination of gamete donor anonymity, preimplantation genetic testing (PGT), and non-invasive prenatal testing (NIPT), as well as an understanding of the underlying causes of male and female infertility.

PGD/PGS (Preimplantation Genetic Diagnosis and preimplantation Genetic Screening) has become more common in IVF clinics over the years, assisting thousands of patients in having healthy babies. With the rapid advancement of biotechnologies, new methods have been developed to reduce the negative impact on embryo development while increasing the accuracy and efficiency of PGD/PGS. Meanwhile, several new non-invasive sampling methods, such as time-lapse imaging technology, BF sampling, and cell-free nucleic acid collection, have been introduced into the field.

Limitations associated with the genetic diagnosis is expected to hamper the market 

Preimplantation genetic testing cannot detect all genetic abnormalities in a fetus. For example, it cannot detect all microdeletions or microduplications, nor can it detect de novo pathogenic variants. Patients and health care providers should be aware that a negative preimplantation genetic test result does not guarantee the birth of a child free of genetic abnormalities. Counselling about prenatal genetic screening or testing should be a collaborative process centred on the patient&#39;s risk, reproductive goals, and preferences.

Preimplantation genetic testing has many limitations, including difficulties in detecting microdeletions and microduplications, de novo variants, and imprinting disorders. The detection of mosaicism during preimplantation genetic testing-aneuploidy-has emerged as a new problem. Mosaicism is defined as the presence of two or more cell populations with different chromosomal complements in the same embryo.

COVID-19 Impact Analysis 

The global preimplantation genetic diagnosis market was moderately affected. It is not clear whether the COVID-19 pandemic influenced pregnant women&#39;s decision to use prenatal genetic tests. The virus elicited a rapid and massive response across healthcare systems, with telehealth implementation serving as a key component of these changes to reduce the risk of viral exposure among patients, healthcare providers, and communities, given the potential effects of COVID-19 on maternal and neonatal outcomes, as well as the importance of prenatal genetic testing for the delivery of high-quality prenatal care. Most of the diagnosis and testing procedures were postponed or delayed. At the same time, most people were scared that they would get infected. Hence, the market was affected by the impact of COVID-19 partially.

<h3>Segment Analysis</h3>

Aneuploidy test type is projected to dominate the market in the forecast period

Aneuploidy is a genetic disorder that occurs due to an abnormal number of chromosomes, such as a human cell with 45 or 47 chromosomes instead of the usual 46. The increasing incidence of aneuploidy and its diagnosis is expected to drive the preimplantation genetic diagnosis market. For instance, the most common aneuploidies in humans are trisomies, accounting for about 0.3 per cent of live births. Trisomies are distinguished by an additional chromosome, bringing the total number of chromosomes to 47. Trisomies, with a few exceptions, do not appear to be compatible with life. Trisomies account for approximately 35% of spontaneous abortions.

Preimplantation genetic testing-aneuploidy has been proposed as a method to detect whole chromosome aneuploidy before the transfer, potentially increasing live birth rates and decreasing early pregnancy failure rates. The original technique, which used fluorescence in situ hybridization, was limited to a few chromosomes. Preimplantation genetic testing-aneuploidy has now been expanded to include evaluation of all chromosomes using techniques such as array comparative genomic hybridization and next-generation sequencing.PGT-A is primarily used to screen embryos for whole-chromosome abnormalities. Before its use, the selection of embryos for transfer was primarily based on morphologic criteria, but many women did not achieve pregnancy despite the transfer of morphologically optimal embryos.

Global Preimplantation Genetic Diagnosis Market-Geographical Analysis

The global preimplantation genetic diagnosis market is expected to grow in the North America region in the forecast period

The presence of better healthcare facilities in this region is expected to boost the market in the forecast period. Pre-implantation genetic diagnosis (PGD) is offered by more than 75% of fertility clinics in the United States, and PGD is used in 4&ndash;6% of IVF procedures each year. While PGS can screen for aneuploidy in IVF patients, PGD is also commonly used to screen for specific genetic disorders.

In 2018, 306,197 ART cycles were performed in the United States. Because of ART, approximately 73,831 live births occurred that year. In the United States, IVF has resulted in over one million babies. Thirty-three per cent of IVF mothers become pregnant during their first cycle. The rise in IVF procedures is expected to increase the market growth of the preimplantation genetic diagnosis market.

<h3>Competitive Landscape</h3>

The global preimplantation genetic diagnosis market is moderately competitive with the company&#39;s investments, mergers and launches. Some of the major key players in the market are Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.), Abbott Laboratories, Natera, Inc., Takara Bio Usa Holdings, Inc., Yikon Genomics, Invicta Genetics

Agilent Technologies, Inc.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 

Overview:&nbsp;Agilent Technologies, Inc. is an American analytical instrument development and manufacturing company that serves markets worldwide with its products and services. The company&#39;s global headquarters are in Santa Clara, California. The company was founded as a spin-off by Hewlett-Packard in 1999.

Product Portfolio:&nbsp;The company&rsquo;s Agilent OnePGT contains reagents for genome-wide amplification, library preparation, and software and cloud services.

Key Development:&nbsp;On October 30, 2018, Agilent Technologies Inc. launched Agilent OnePGT, a genome-wide next-generation sequencing (NGS) solution for preimplantation genetic testing (PGT).

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/comprehensive-metabolic-panel-market">Comprehensive Metabolic Panel Market</a>

<a href="https://www.datamintelligence.com/research-report/direct-to-consumer-dna-test-kits-market">DTC (Direct to Consumer) DNA Test Kits Market</a>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	Methodology and Scope

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	Market Definition and Overview
	</li>
	<li>
	Executive Summary

	<ol>
		<li>Market Snippet By Product Type</li>
		<li>Market Snippet By Technology</li>
		<li>Market Snippet By Application</li>
		<li>Market Snippet By Region</li>
	</ol>
	</li>
	<li>
	Market Dynamics

	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>The advancement in the diagnostic procedures in gene testing</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>Limitations associated with the genetic diagnosis</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Industry Analysis 

	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>
	COVID-19 Analysis

	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	By Product Type

	<ol>
		<li>Introduction</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
		<li>Market Attractiveness Index, By Product Type
		<ol>
			<li>Reagents &amp; Consumables*
			<ol>
				<li>
				<ol>
					<li>Introduction</li>
					<li>Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
				</ol>
				</li>
			</ol>
			</li>
			<li>Instruments</li>
			<li>Software &amp; Services</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	By Technology

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Attractiveness Index, By Technology</li>
		</ol>
		</li>
		<li>Next Generation Sequencing (NGS)
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Polymerase Chain Reaction (PCR)</li>
		<li>Comparative Genomic Hybridization (CGH)</li>
		<li>Other</li>
	</ol>
	</li>
	<li>
	By Application

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Aneuploidy*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Structural Chromosomal Abnormalities</li>
		<li>Single Gene Disorders</li>
		<li>X-linked Disorders</li>
		<li>Gender Identification</li>
		<li>Other</li>
	</ol>
	</li>
	<li>
	By Region

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Competitive Landscape

	<ol>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
	</ol>
	</li>
	<li>
	Global Preimplantation Genetic Diagnosis Market- Company Profiles

	<ol>
		<li>Agilent Technologies, Inc.*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Illumina , Inc</li>
		<li>Thermo Fisher Scientific Inc.</li>
		<li>Perkinelmer, Inc.</li>
		<li>Coopersurgical, Inc.</li>
		<li>Abbott Laboratories</li>
		<li>Natera, Inc.</li>
		<li>Takara Bio Usa Holdings, Inc.</li>
		<li>Yikon Genomics</li>
		<li>Invicta Genetics(*LIST NOT EXHAUSTIVE )</li>
	</ol>
	</li>
	<li>
	DataM Intelligence&nbsp;&nbsp; 

	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables

Table 01&nbsp;&nbsp; Global Preimplantation Genetic Diagnosis Market, By Product Type, 2021, 2025 &amp; 2029 ($ Million)

Table 02&nbsp;&nbsp; Global Preimplantation Genetic Diagnosis Market, By Technology, 2021, 2025 &amp; 2029 ($ Million)

Table 03 &nbsp; Global Preimplantation Genetic Diagnosis Market Value, By Application, 2021, 2025 &amp; 2029 ($ Million)

Table 04 Global Preimplantation Genetic Diagnosis Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 05&nbsp;&nbsp; Global Preimplantation Genetic Diagnosis Market Value, By Product Type, 2021, 2025 &amp; 2029 ($ Million)

Table 06&nbsp; Global Preimplantation Genetic Diagnosis Market Value, By Product Type, 2021, 2025 &amp; 2029 ($ Million)

Table 07&nbsp;&nbsp; Global Preimplantation Genetic Diagnosis Market Value, By Technology, 2021, 2025 &amp; 2029 ($ Million)

Table 08&nbsp; Global Preimplantation Genetic Diagnosis Market Value, By Technology, 2019-2029 ($ Million)

Table 09&nbsp; Global Preimplantation Genetic Diagnosis Market Value, By Application, 2021, 2025 &amp; 2029 ($ Million)

Table 10&nbsp;&nbsp; Global Preimplantation Genetic Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 11 Global Preimplantation Genetic Diagnosis Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 12&nbsp;&nbsp; Global Preimplantation Genetic Diagnosis Market Value, By Region, 2019-2029 ($ Million)

Table 13&nbsp;&nbsp; North America Preimplantation Genetic Diagnosis Market Value, By Product Type, 2019-2029 ($ Million)

Table 14&nbsp;&nbsp; North America Preimplantation Genetic Diagnosis Market Value, By Technology, 2019-2029 ($ Million)

Table 15&nbsp;&nbsp; North America Preimplantation Genetic Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 16&nbsp;&nbsp; North America Preimplantation Genetic Diagnosis Market Value, By Country, 2019-2029 ($ Million)

Table 17&nbsp;&nbsp; South America Preimplantation Genetic Diagnosis Market Value, By Product Type, 2019-2029 ($ Million)

Table 18&nbsp;&nbsp; South America Preimplantation Genetic Diagnosis Market Value, By Technology, 2019-2029 ($ Million)

Table 19&nbsp;&nbsp; South America Preimplantation Genetic Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 20&nbsp;&nbsp; South America Preimplantation Genetic Diagnosis Market Value, By Country, 2019-2029 ($ Million)

Table 21&nbsp;&nbsp; Europe Preimplantation Genetic Diagnosis Market Value, By Product Type, 2019-2029 ($ Million)

Table 22&nbsp;&nbsp; Europe Preimplantation Genetic Diagnosis Market Value, By Technology, 2019-2029 ($ Million)

Table 23&nbsp;&nbsp; Europe Preimplantation Genetic Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 24&nbsp;&nbsp; Europe Preimplantation Genetic Diagnosis Market Value, By Country, 2019-2029 ($ Million)

Table 25&nbsp;&nbsp; Asia-Pacific Preimplantation Genetic Diagnosis Market Value, By Product Type, 2019-2029 ($ Million)

Table 26&nbsp;&nbsp; Asia-Pacific Preimplantation Genetic Diagnosis Market Value, By Technology, 2019-2029 ($ Million)

Table 27&nbsp;&nbsp; Asia-Pacific Preimplantation Genetic Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 28&nbsp;&nbsp; Asia-Pacific Preimplantation Genetic Diagnosis Market Value, By Country, 2019-2029 ($ Million)

Table 29&nbsp;&nbsp; Middle East &amp; Africa Preimplantation Genetic Diagnosis Market Value, By Product Type, 2019-2029 ($ Million)

Table 30&nbsp;&nbsp; Middle East &amp; Africa Preimplantation Genetic Diagnosis Market Value, By Technology, 2019-2029 ($ Million)

Table 31&nbsp;&nbsp; Middle East &amp; Africa Preimplantation Genetic Diagnosis Market Value, By Application, 2019-2029 ($ Million)

Table 32&nbsp;&nbsp; Agilent Technologies, Inc.: Overview

Table 33&nbsp;&nbsp; Agilent Technologies, Inc.: Product Portfolio

Table 34&nbsp;&nbsp; Agilent Technologies, Inc.: Key Developments

Table 35&nbsp;&nbsp; Illumina , Inc: Overview

Table 36&nbsp;&nbsp; Illumina , Inc: Product Portfolio

Table 37&nbsp;&nbsp; Illumina , Inc: Key Developments

Table 38&nbsp;&nbsp; Thermo Fisher Scientific Inc.: Overview

Table 39&nbsp;&nbsp; Thermo Fisher Scientific Inc.: Product Portfolio

Table 40&nbsp; Thermo Fisher Scientific Inc.: Key Developments

Table 41&nbsp;&nbsp; Perkinelmer, Inc.: Overview

Table 42&nbsp;&nbsp; Perkinelmer, Inc.: Product Portfolio

Table 43&nbsp;&nbsp; Perkinelmer, Inc.: Key Developments

Table 44&nbsp; Coopersurgical, Inc.: Overview

Table 45&nbsp;&nbsp; Coopersurgical, Inc.: Product Portfolio

Table 46&nbsp; Coopersurgical, Inc.: Key Developments

Table 47&nbsp;&nbsp; Abbott Laboratories: Overview

Table 48&nbsp; Abbott Laboratories: Product Portfolio

Table 49&nbsp; Abbott Laboratories: Key Developments

Table 50&nbsp;&nbsp; Natera, Inc.: Overview

Table 51&nbsp;&nbsp; Natera, Inc.: Product Portfolio

Table 52&nbsp;&nbsp; Natera, Inc.: Key Developments

Table 53&nbsp;&nbsp; Takara Bio Usa Holdings, Inc.: Overview

Table 54&nbsp;&nbsp; Takara Bio Usa Holdings, Inc.: Product Portfolio

Table 55&nbsp;&nbsp; Takara Bio Usa Holdings, Inc.: Key Developments

Table 56&nbsp;&nbsp; Yikon Genomics: Overview

Table 57&nbsp;&nbsp; Yikon Genomics: Product Portfolio

Table 58&nbsp;&nbsp; Yikon Genomics: Key Developments

Table 59&nbsp;&nbsp; Invicta Genetics: Overview

Table 60&nbsp; Invicta Genetics: Product Portfolio

Table 61&nbsp;&nbsp; Invicta Genetics: Key Developments

List of Figures

Figure 01 Global Preimplantation Genetic Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 02 Global Preimplantation Genetic Diagnosis Market Share, By Technology, 2021 &amp; 2029 (%)

Figure 03 Global Preimplantation Genetic Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 04 Global Preimplantation Genetic Diagnosis Market Share, By Region, 2021 &amp; 2029 (%)

Figure 05 Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 06 Global Preimplantation Genetic Diagnosis Market Y-o-Y Growth, By Product Type, 2021-2029 (%)

Figure 07 Reagents &amp; Consumables: Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 08 Instruments: Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 09 Software &amp; Services: Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 10 Global Preimplantation Genetic Diagnosis Market Y-o-Y Growth, By Technology, 2021-2029 (%)

Figure 11&nbsp; Next Generation Sequencing (NGS): Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 12&nbsp; Polymerase Chain Reaction (PCR): Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 13&nbsp; Comparative Genomic Hybridization (CGH): Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 14 Other: Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 15&nbsp; Global Preimplantation Genetic Diagnosis Market Y-o-Y Growth, By Application, 2021-2029 (%)

Figure 16 Aneuploidy: Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 17&nbsp; Structural Chromosomal Abnormalities: Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 18 Single Gene Disorders: Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 19 X-linked Disorders: Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 20 Gender Identification: Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 21&nbsp; Other: Global Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 22 Global Preimplantation Genetic Diagnosis Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 23 North America Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 24 North America Preimplantation Genetic Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 25 North America Preimplantation Genetic Diagnosis Market Share, By Technology, 2021 &amp; 2029 (%)

Figure 26 North America Preimplantation Genetic Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 27 North America Preimplantation Genetic Diagnosis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 28 South America Preimplantation Genetic Diagnosis Market Share, 2019-2029 ($ Million)

Figure 29 South America Preimplantation Genetic Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 30 South America Preimplantation Genetic Diagnosis Market Share, By Technology, 2021 &amp; 2029 (%)

Figure 31&nbsp; South America Preimplantation Genetic Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 32 South America Preimplantation Genetic Diagnosis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 33 Europe Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 34 Europe Preimplantation Genetic Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 35 Europe Preimplantation Genetic Diagnosis Market Share, By Technology, 2021 &amp; 2029 (%)

Figure 36 Europe Preimplantation Genetic Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 37 Europe Preimplantation Genetic Diagnosis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 38 Asia-Pacific Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 39 Asia-Pacific Preimplantation Genetic Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 40 Asia-Pacific Preimplantation Genetic Diagnosis Market Share, By Technology, 2021 &amp; 2029 (%)

Figure 41 Asia-Pacific Preimplantation Genetic Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 42 Asia-Pacific Preimplantation Genetic Diagnosis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 43 Middle East &amp; Africa Preimplantation Genetic Diagnosis Market Value, 2019-2029 ($ Million)

Figure 44 Middle East &amp; Africa Preimplantation Genetic Diagnosis Market Share, By Product Type, 2021 &amp; 2029 (%)

Figure 45 Middle East &amp; Africa Preimplantation Genetic Diagnosis Market Share, By Technology, 2021 &amp; 2029 (%)

Figure 46 Middle East &amp; Africa Preimplantation Genetic Diagnosis Market Share, By Application, 2021 &amp; 2029 (%)

Figure 47 Agilent Technologies, Inc.: Financials

Figure 48 Illumina , Inc: Financials

Figure 49 Thermo Fisher Scientific Inc.: Financials

Figure 50 Perkinelmer, Inc.: Financials

Figure 51&nbsp; Coopersurgical, Inc.: Financials

Figure 52 Abbott Laboratories: Financials

Figure 53 Natera, Inc.: Financials

Figure 54 Takara Bio Usa Holdings, Inc.: Financials

Figure 55 Yikon Genomics: Financials

Figure 56 Invicta Genetics: Financials